Adjunctive intravenous immunoglobulins (IVIg) for moderate-severe COVID-19: emerging therapeutic roles

Curr Med Res Opin. 2021 Mar 15:1. doi: 10.1080/03007995.2021.1903849. Online ahead of print.NO ABSTRACTPMID:33722106 | DOI:10.1080/03007995.2021.1903849

Source: Current Medical Research and Opinion - March 16, 2021 Category: Research Authors: Felix Bongomin Lucy Grace Asio Kenneth Ssebambulidde Joseph Baruch Baluku Source Type: research